ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Molecular Classifier of Antibody-Mediated Rejection Is a Better Predictor of Histologic Rejection Than a Corresponding Transcript Set and Is Further Improved When Combined with Classifiers of Rejection Syndromes.

K. Famulski, P. Halloran.

University of Alberta, Edmonton, AB, Canada

Meeting: 2017 American Transplant Congress

Abstract number: B58

Keywords: Gene expression, Kidney transplantation, Prediction models, Rejection

Session Information

Session Name: Poster Session B: Antibody Mediated Rejection in Kidney Transplant Recipients II

Session Type: Poster Session

Date: Sunday, April 30, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Molecular and histologic changes in graft rejection are not completely specific, often being induced by injuries and other diseases. We examined various methods for using molecules to predict rejection: molecular gene set means, single molecular classifiers derived by machine learning, and multiple classifiers.

We derived top 20 transcripts associated with (by t-test) histologic antibody-mediated rejection (ABMR) comparing biopsies with ABMR to biopsies with no rejection – everything else (EE) but including T cell-mediated rejection (TCMR) in the comparator, the AvsEET algorithm. The same algorithm was used to build a molecular classifier of ABMR, which used 20 transcripts selected by machine learning to obtain a classifier score.

Next, we compared the classifier scores to the gene set means. Logistic regression was used to predict the presence/absence of disease in a training set and then applied to the test set. AvEET classifier had better area under the curve (AUC) than the ABMR transcript set mean (0.84 vs. 0.80, respectively) (Figure 1 upper panel). To find if we can get better performance of AvsEET classifier, we built additional all rejection (ABMR, TCMR, Mixed) classifier (RvsEE) and TCMR classifier with ABMR in the comparator (TvsEEA) then combined them with the AvsEE classifier and again tested the prediction of histologic diagnosis of ABMR.

Combined classifiers improved the ability to predict histologic ABMR (AUC 0.86) compared to using the ABMR classifier alone, as demonstrated by the Net Reclassification Index (Figure 1, lower panel).

Thus the AvsEE molecular classifier is superior to the AvsEE transcript set mean in predicting histologic ABMR diagnoses, but the combination of three classifiers (RvEE, TvEEA, and AvEET) is superior to either a single classifier or to a transcript set means for predicting ABMR.

CITATION INFORMATION: Famulski K, Halloran P. Molecular Classifier of Antibody-Mediated Rejection Is a Better Predictor of Histologic Rejection Than a Corresponding Transcript Set and Is Further Improved When Combined with Classifiers of Rejection Syndromes. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Famulski K, Halloran P. Molecular Classifier of Antibody-Mediated Rejection Is a Better Predictor of Histologic Rejection Than a Corresponding Transcript Set and Is Further Improved When Combined with Classifiers of Rejection Syndromes. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/molecular-classifier-of-antibody-mediated-rejection-is-a-better-predictor-of-histologic-rejection-than-a-corresponding-transcript-set-and-is-further-improved-when-combined-with-classifiers-of-rejectio/. Accessed May 28, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences